GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $53,000 | -26.4% | 13,620 | -0.5% | 0.00% | – |
| Q3 2022 | $72,000 | -90.9% | 13,690 | -56.7% | 0.00% | – |
| Q3 2021 | $793,000 | +31.3% | 31,642 | +41.0% | 0.00% | – |
| Q2 2021 | $604,000 | +3.4% | 22,435 | +9.3% | 0.00% | – |
| Q1 2021 | $584,000 | -16.9% | 20,522 | -17.3% | 0.00% | – |
| Q4 2020 | $703,000 | +15.4% | 24,806 | +25.9% | 0.00% | – |
| Q3 2020 | $609,000 | +15.1% | 19,706 | -21.7% | 0.00% | – |
| Q2 2020 | $529,000 | – | 25,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |